Skip to main content
. 2020 Dec 12;10(4):274. doi: 10.3390/jpm10040274

Table 2.

Single-pulse transcranial magnetic stimulation (TMS) data obtained from all participants.

Variable Group 1 (Controls; n = 28) Group 2 (PD; n = 28) Group 3 (PSP; n = 23) Kruskal–Wallis ANOVA post hoc
Median Lower Upper Median Lower Upper Median Lower Upper H(2,37) p Effect Size Cohen’s d 1 vs. 2 1 vs. 3 2 vs. 3
p p p
Right FDI MEP amplitude, mV 3.9 2.3 5.1 7.9 6.4 10.2 7.9 5.6 11.1 23.879 0.00001 1.272 0.00001 0.00015 NS
Right FDI MEP latency, ms 20.7 19.9 21.9 20.4 19.3 21.3 19.7 18.6 21.2 4.407 NS 0.362 - - -
Right FDI CMCT, ms 6.5 6.0 7.3 5.9 5.3 6.3 5.9 5.2 6.8 8.063 NS 0.589 - - -
Right FDI rMT, % 43.0 39.0 45.5 37.5 35.0 45.5 39.0 34.0 49.0 3.178 NS 0.251 - - -
Right FDI CSP, ms 69.4 58.5 87.2 125.4 95.0 135.2 131.8 92.8 162.0 23.131 0.0001 1.241 0.00007 0.00004 NS
Left FDI MEP amplitude, mV 4.6 4.0 6.0 6.1 4.2 8.2 6.4 4.0 9.2 3.234 NS 0.257 - - -
Left FDI MEP latency, ms 19.2 18.4 20.6 20.1 19.5 21.1 19.3 18.1 21.1 5.262 NS 0.424 - - -
Left FDI CMCT, ms 5.5 5.1 6.5 5.9 5.1 6.5 5.8 4.9 6.8 0.406 NS - - - -
Left FDI rMT, % 40.0 38.0 43.5 38.0 35.0 41.5 41.0 36.0 44.0 3.247 NS 0.258 - - -
Left FDI CSP, ms 74.5 60.5 117.0 131.5 79.3 139.0 146.3 101.0 151.0 12.807 0.0017 0.814 0.035 0.00062 NS

Legend (in alphabetical order): CMCT: central motor conduction time; CSP: cortical silent period; FDI: First Dorsal Interosseous muscle; K–W: Kruskal–Wallis; MEP: motor evoked potential; NS: not significant; PD: Parkinson’s disease; PSP: Progressive Supranuclear Palsy; rMT: resting motor threshold; TMS: transcranial magnetic stimulation; numbers in bold: statistically significant p value sand large (>0.8) effect sizes.